Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hironobu Arai

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Urology Case Reports|October 26, 2020
Spontaneous rupture of a hybrid oncocytic chromophobe tumor: A case reportYuki Matsuoka, Yoko Matsuda, Hironobu Arai, et al.
Cureus|December 29, 2025
Real-World Clinical Outcomes of Darolutamide in Older Patients With Non-metastatic Castration-Resistant Prostate Cancer: A Multi-institutional Comparative Analysis of Efficacy and TolerabilityYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Clinical Oncology|February 28, 2024
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort studyRikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Urology Case Reports|October 26, 2020
Spontaneous rupture of a hybrid oncocytic chromophobe tumor: A case reportYuki Matsuoka, Yoko Matsuda, Hironobu Arai, et al.
Cureus|December 29, 2025
Real-World Clinical Outcomes of Darolutamide in Older Patients With Non-metastatic Castration-Resistant Prostate Cancer: A Multi-institutional Comparative Analysis of Efficacy and TolerabilityYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Clinical Oncology|February 28, 2024
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort studyRikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, et al.
Pageof 1